Erlotinib Concurrent With Radiation Therapy in Non-small-cell Lung Cancer
Phase 2
- Conditions
- Carcinoma, Non-Small Cell Lung
- Interventions
- Other: Radiation Therapy and EGFR-TKI target therapy
- First Posted Date
- 2009-09-09
- Last Posted Date
- 2015-12-22
- Target Recruit Count
- 50
- Registration Number
- NCT00973310
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute and Hospital, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin, China
© Copyright 2025. All Rights Reserved by MedPath